Jonathan Lim, Lead of The Christie International Fellowship Programme for Medical Oncology at The Christie NHS Foundation Trust, Lead of RISE Consortium at RISE Manchester, shared a post on LinkedIn:
“Congratulations to Dr. Rachel Woodford, the most recent alumnus of our Advanced Immunotherapy and Cell Therapy (AICT) team.
Over the past year, Rachel worked across our first-in-human and early-phase trials in immunotherapy and cell therapy for solid tumours, as well as produced original research alongside the clinical work.
We are delighted that she’s now been appointed Consultant Medical Oncologist in Experimental Cancer Medicines at The Christie NHS Foundation Trust and, happily, not going far.
Congratulations, Rachel! Looking forward to continuing to work together as colleagues.”
Other articles featuring Jonathan Lim on OncoDaily.